Investors send canadian pot stock soaring on possible Marlboro tobacco deal

New York (CNN Business)The company that makes Marlboro cigarettes may be looking for a new vice. Altria could find that the red-hot cannabis industry is a much-needed supplement to its stagnant tobacco business.

Canadian cannabis company Cronos Group surged Monday after Reuters reported Altria may want to buy the company. The stock was up nearly 30% at one point before it was briefly halted for trading midday Monday. Shares were still up 12% when trading resumed.

Cronos confirmed in a statement that it was discussing a potential investment by Altria, but Cronos said the two companies had not yet reached an agreement. Altria was not immediately available for comment.

Cronos, Aphria and other cannabis stocks have been thrust into the spotlight in the past few months following the legalization of recreational marijuana in Canada in October, as well as legalized recreational and medical pot in several US states last month.

Read More:  Pot stock soaring

Cannabinoid Hyperemesis Syndrome

Coinciding with the increasing rates of cannabis abuse and legalization has been the recognition of a new clinical condition known as Cannabinoid Hyperemesis Syndrome.

Cannabinoid hyperemesis syndrome (CHS) was first described in Australia in 2004

Cannabinoid hyperemesis syndrome is a condition experienced by chronic marijuana users who develop symptoms like severe nausea, vomiting and abdominal pain, which are characteristically relieved by hot showers.

Topical capsaicin cream was also found to provide temporarily adequate relief of symptoms.

Diagnosing this condition can be extremely expensive ruling out more serious medical conditions considering CHS is relatively unknown by doctors.

If your cannabis consumption is heavy, you risk developing Cannabinoid Hyperemesis Syndrome

Read More